Katarzyna Plebanek-Jozwik

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Long-term toxicity of tandem radioligand therapy using [90Y]Y/[177Lu]Lu-DOTA-TATE in neuroendocrine tumors: a polish multicenter experience with 20-year follow-up.

Long-term toxicity of tandem radioligand therapy using [90Y]Y/[177Lu]Lu-DOTA-TATE in neuroendocrine tumors: a polish multicenter experience with 20-year follow-up.

Journal: European journal of nuclear medicine and molecular imaging
Published: February 10, 2026

The impact of radioligand therapy on prognosis in patients with lung neuroendocrine tumors.

The impact of radioligand therapy on prognosis in patients with lung neuroendocrine tumors.

Journal: Frontiers in endocrinology
Published: November 03, 2025

Bronchogenic cyst mimicking metastatic disease on post-radioiodine scintigraphy in a patient with papillary thyroid carcinoma.

Bronchogenic cyst mimicking metastatic disease on post-radioiodine scintigraphy in a patient with papillary thyroid carcinoma.

Journal: Nuclear medicine review. Central & Eastern Europe
Published: September 30, 2025

Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.

Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.

Journal: Frontiers in endocrinology
Published: September 30, 2025

Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors.

Assessment of Early Cardiotoxicity and Cardiac Dysfunction of Radioligand Therapy in Patients with Neuroendocrine Tumors.

Journal: Cancers
Published: September 06, 2025

The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

The Polish radioligand therapy (RLT) Registry: initial real-world evidence in neuroendocrine tumors.

Journal: Nuclear medicine review. Central & Eastern Europe
Published: September 02, 2025

Complications and outcomes of radioligand therapy in patients with neuroendocrine neoplasms depending on the baseline glomerular filtration rate.

Complications and outcomes of radioligand therapy in patients with neuroendocrine neoplasms depending on the baseline glomerular filtration rate.

Journal: European journal of nuclear medicine and molecular imaging
Published: May 03, 2025

Oritavancin in LVAD related infections - a chance for shortening therapy and improving outcomes.

Oritavancin in LVAD related infections - a chance for shortening therapy and improving outcomes.

Journal: BMC infectious diseases
Published: April 29, 2025

A rare case of follicular thyroid carcinoma with unknown primary tumor location.

A rare case of follicular thyroid carcinoma with unknown primary tumor location.

Journal: Nuclear medicine review. Central & Eastern Europe
Published: March 23, 2025

Thymic well-differentiated neuroendocrine tumor with isolated bone marrow metastases: an unusual metastatic pattern.

Thymic well-differentiated neuroendocrine tumor with isolated bone marrow metastases: an unusual metastatic pattern.

Journal: Endokrynologia Polska
Published: March 15, 2025

The Use of [11C]C-Methionine in Diagnostics of Endocrine Disorders with Focus on Pituitary and Parathyroid Glands.

The Use of [11C]C-Methionine in Diagnostics of Endocrine Disorders with Focus on Pituitary and Parathyroid Glands.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 07, 2025

Theranostics in Renal Cell Carcinoma-A Step Towards New Opportunities or a Dead End-A Systematic Review.

Theranostics in Renal Cell Carcinoma-A Step Towards New Opportunities or a Dead End-A Systematic Review.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 04, 2024
Showing 1-12 of 36

Last Updated: 09/26/2026